利用研究成果来优化前列腺癌护理
Brock O'Neil1, Matthew J Resnick1,2
1Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Urology practice
|August 18, 2023
概括
将患者报告的结果措施 (PROM) 和决策辅助工具整合到局部性前列腺癌护理中,可以提高患者的决策能力. 推使用扩张前列腺指数复合短形式 (EPIC-SF) 等工具来跟踪结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 局部性前列腺癌的治疗涉及多种选择,具有不同的副作用,使患者的偏好至关重要.
- 患者报告的结果措施 (PROM) 和决策辅助工具可以增强共享决策并改善患者的结果.
- 当前的临床实践面临着整合这些宝贵的以患者为中心的工具的障碍.
研究的目的:
- 审查关于PROMs和局部前列腺癌管理的决策辅助工具的文献.
- 讨论这些工具在临床实践中的重要性和实施挑战.
- 推特定的工具和策略,以实现成功的整合.
主要方法:
- 对PROMs和局部前列腺癌的决策辅助器的研究进行系统文献综述.
- 综合了关于这些工具的影响和实用性的关键发现.
- 确定临床实施的障碍和促进因素.
主要成果:
- 高质量的PROM,如扩大前列腺指数复合短形式 (EPIC-SF),在临床环境中越来越多地被采用.
- 决策辅助可明显提高患者的知识和满意度,并减少不确定性.
- 提供商的参与和建立的办公协议可以克服实施障碍.
结论:
- 将PROM和决策辅助工具纳入临床实践对于改善前列腺癌护理中共享决策质量至关重要.
- 为了成功整合这些以患者为中心的工具,需要周到的实施策略.
- 建议使用EPIC-SF用于局部性前列腺癌的标准化结果测量.
更多相关视频
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
16.6K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
相关概念视频
Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
Guidelines for Writing Outcome
2.8K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
147
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
147
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
